The parties argued that the VAM shortage persists to date since, according to some publications, US producers continue to invoke force majeure on VAM deliveries and therefore it cannot be concluded that there will be a return to normal production volumes.
16 2. EXAMINATION OF CHANGED MARKET CONDITIONS › 2.2. Analysis of changes of market conditions during the suspension IP, Decision_act (EU) 2022/1397
In forcesince 11 Aug 2022